Cargando…
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although several effective vaccines continue to be deployed, reliable antiviral treatments have yet to be developed against this dis...
Autores principales: | Saha, Tushar, Quiñones-Mateu, Miguel E., Das, Shyamal C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296254/ https://www.ncbi.nlm.nih.gov/pubmed/35868481 http://dx.doi.org/10.1016/j.ijpharm.2022.122042 |
Ejemplares similares
-
Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
por: Saha, Tushar, et al.
Publicado: (2022) -
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
por: Saha, Tushar, et al.
Publicado: (2023) -
Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization
por: Eedara, Basanth Babu, et al.
Publicado: (2023) -
Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization
por: Momin, Mohammad A. M., et al.
Publicado: (2021) -
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation
por: Khadka, Prakash, et al.
Publicado: (2022)